Carcinogenic pollutants o-nitroanisole and o-anisidine are substrates and inducers of cytochromes P450.
Helena Rýdlová, Markéta Miksanová, Helena Ryslavá, Marie Stiborová
Index: Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 149(2) , 441-7, (2005)
Full Text: HTML
Abstract
2-Methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole) are important pollutants and potent carcinogens for rodents. o-Anisidine is oxidized by microsomes of rats and rabbits to N-(2-methoxyphenyl)hydroxylamine that is also formed as the reduction metabolite of o-nitroanisole. o-Anisidine is a promiscuity substrate of rat and rabbit cytochrome P450 (CYP) enzymes, because CYPs of 1A, 2B, 2E and 3A subfamilies oxidize o-anisidine. Using purified CYP enzymes, reconstituted with NADPH: CYP reductase, rabbit CYP2E1 was the most efficient enzyme oxidizing o-anisidine, but the ability of CYP1A1, 1A2, 2B2, 2B4 and 3A6 to participate in o-anisidine oxidation was also proved. Utilizing Western blotting and consecutive immunoquantification employing chicken polyclonal anti bodies raised against various CYPs, the effect of o-anisidine and o-nitroanisole on the expression of the CYP enzymes was investigated. The expression of CYP1A1/2 was found to be strongly induced in rats treated with either compounds. In addition, 7-ethoxyresorufin O-deethylation, a marker activity for both CYP1A1 and 1A2, was significantly increased in rats treated with either carcinogen. The data demonstrate the participation of different rat and rabbit CYP enzymes in o-anisidine oxidation and indicate that both experimental animal species might serve as suitable models to mimic the o-anisidine oxidation in human. Furthermore, by induction of rat hepatic and renal CYP1A1/2, both o-nitroanisole and o-anisidine influence their carcinogenic effects, modifying their detoxification and/or activation pathways.
Related Compounds
Related Articles:
2014-12-01
[Regul Toxicol Pharmacol 70 Suppl 1 , S2-14, (2014)]
2009-05-01
[Int. J. Hyg. Environ. Health 212(3) , 298-309, (2009)]
2008-08-01
[Chem. Res. Toxicol. 21(8) , 1610-21, (2008)]
2005-09-20
[Int. J. Cancer 116(5) , 667-78, (2005)]
2004-05-01
[J. Nanosci. Nanotechnol. 4(5) , 548-52, (2004)]